Quotient Partners with Transmedic for Healthcare Expansion in Southeast Asia

Quotient and Transmedic sign distribution agreement in Southeast Asia

Quotient and Transmedic have signed a distribution agreement, which will enable Transmedic to distribute Alba by Quotient® and MosaiQ™ in five countries in Southeast Asia.This significant partnership reaffirms Quotient’s commitment to grow and expand its geographical presence. It will enable both parties to introduce new quality services to the healthcare industry in Southeast Asia and enhance patient care.With a history spanning over four decades, Transmedic is a leader in medical technology. Headquartered in Singapore, the company operates in Southeast Asia. It is active in the distribution of medical devices and specialized drugs, education, and post-sales support.The distribution agreement takes effect immediately and will cover the following five countries in Southeast Asia:

Indonesia
Malaysia
Singapore
Thailand
Vietnam

Transmedic will be able to distribute the Alba by Quotient portfolio, our range of high-quality reagents, along with the MosaiQ solution, which is currently under development and aims to facilitate fast and accurate test results in the autoimmune diseases and allergy fields.“We are thrilled to collaborate with such a strong partner and to be able to expand our operations in Southeast Asia,” said Khaled Hamed, Quotient’s Head of APAC.To find out more about Transmedic, please visit their website: www.transmedicgroup.com

AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, sign a distribution agreement for Australia and New Zealand

AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, have signed a distribution agreement, which will enable Bio-Strategy to distribute the LumiQ™ solution in Australia and New Zealand. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to

Quotient and Transmedic sign distribution agreement in Southeast Asia

Quotient and Transmedic sign distribution agreement in Southeast Asia

Trending Topics

AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, sign a distribution agreement for Australia and New Zealand

Join us at EuroMedLab 2025

AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S sign Distribution Agreement in Türkiye

AliveDx Suisse S.A. and Vital Care SPA sign distribution agreement in Algeria

Alba Bioscience Limited and Medline Industries, LP sign distribution agreement for Alba reagents in the USA

Join our webinar with Dr. Gerber Gomez: Multiplex Autoantibody Testing in the Serological Evaluation of Autoimmune Disease